Oriental Carbon and Chemicals (OCCL) Q4 10/11 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 10/11 earnings summary
2 Nov, 2026Executive summary
FY11 net sales rose 26% to Rs 15,823.79 lakh; PBT increased to Rs 4,362.74 lakh and PAT to Rs 3,737.93 lakh.
Insoluble Sulphur growth was constrained by capacity; a 11,000 Mtpa Mundra expansion was underway, with both phases expected to be sold into demand.
Financial highlights
Net sales were Rs 15,823.79 lakh vs Rs 12,570.64 lakh; total income reached Rs 16,734.71 lakh vs Rs 12,371.77 lakh.
PBT was Rs 4,362.74 lakh vs Rs 3,427.21 lakh; PAT was Rs 3,737.93 lakh vs Rs 2,945.69 lakh.
Profit before interest, depreciation and tax was Rs 5,180.16 lakh vs Rs 4,137.99 lakh.
Cash from operations was Rs 2,673.60 lakh; net cash used in investing was Rs 5,994.23 lakh, including project and fixed-asset spending.
Outlook and guidance
Mundra Phase 1, adding 5,500 Mtpa, was expected to start in June 2011; output was sold out subject to technical approvals.
Phase 2, also 5,500 Mtpa, was advanced, with major machinery ordered and commissioning targeted for Q4 FY12.
Sulphuric Acid margins were expected under pressure in FY12 due to low first-quarter offtake; Oleum demand weakened amid regional capacity additions.
Latest events from Oriental Carbon and Chemicals
- Profitable growth and a ₹216 crore expansion plan advance the next capacity phase.OCCL
Q4 18/19 - COVID-19 hit FY20 results; FY21 outlook signaled lower sales and delayed expansion.OCCL
Q4 19/20 - Higher FY18 profit and expanding Insoluble Sulphur capacity underpin the growth outlook.OCCL
Q4 17/18 - Higher margins lifted PAT despite weaker sales; Mundra expansion was due in April 2017.OCCL
Q4 15/16 - Mundra expansion and Insoluble Sulphur growth drive the FY2016-17 outlook.OCCL
Q4 16/17 - FY15 profit advanced as Insoluble Sulphur demand and capacity utilization strengthened.OCCL
Q4 14/15 - FY14 growth was led by Insoluble Sulphur, with expansion prospects shadowed by SEZ uncertainty.OCCL
Q4 13/14 - Sales rose, but lower tyre demand and higher costs cut earnings as Mundra Phase II ramped up.OCCL
Q4 12/13 - Revenue grew 37%, while Mundra expansion lifted Insoluble Sulphur capacity amid higher costs and market risks.OCCL
Q4 11/12